Recent Articles By The Author
Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents
The company's shares were up 24% ahead of market's open on an FDA approval.
Mylan Falls on FDA Warning on Quality Control
The EpiPen-maker has received a letter from the FDA about its manufacturing facility in Nashik, India.
Medivation Founder Takes Helm at Axovant, Shares Spike
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
Endo international, AngioDynamics Lead Biotech Movers
Endo International slipped 5% ahead of market's open Friday.
Dollar Store Debacle Bodes Poorly for Walgreens-Rite Aid Merger
Sycamore Partners' attempt to purchase divested dollar stores went poorly. Will the FTC believe Fred's can do better with Rite Aid spinoffs?
Trevena, Synergy Lead Biotech Movers
Positive phase three data was a boon for Trevena, but Synergy's "Poop Troop" put pressure on its stock.
Walgreens Has 'Strong Argument' to Push Rite Aid Deal Passed Regulators, CEO Pessina Says
The two companies initially agreed to an acquisition agreement in October 2015.
Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO
Investors are ticked off about the CEO's bonanza amid dismal results.